Microsoft Corp. (NASDAQ: MSFT) has seen some strong stock price gains recently, closing yesterday up over $36. The world's largest software company saw another outstanding quarter last week, and similar to Google, Inc. (NASDAQ: GOOG), the company just keeps on bypassing naysayers and reporting excellent quarters one after another. If the PC is dead and the operating system is becoming extinct, apparently nobody is telling Redmond.
On the back of great quarterly results, Microsoft's shares have shot up to a six-year high, and it was the largest gainer on Halloween day among the Dow industrials. The $36.67 price from yesterday's trading day was the highest since June 2001, with nearly 100 million shares traded. For a 30-year-old software company seen as un-innovative and boring (well, when compared to Google), Halloween day was a recent milestone in Microsoft's history.
Even last Thursday, almost 290 million shares were traded after Microsoft's Q3 results came back so strong. A Sanford Bernstein analyst said that he expected the company "to continue to exceed expectations" for a while, which added to the flurry of trading as Microsoft's strong results and guidance caused visions of sugar plums to dance in the heads of many investors. Share buybacks, the incredible launch of Halo 3 and the Windows Vista distribution cycle were all cited as factors for strong future performance indicators. Who knew Microsoft would ever be considered a winner of "long-term performance" back in 2005 by analysts?
Disclosure: I own MSFT shares as of 11-1-07.
Last updated: February 10, 2012: 04:57 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- January New Home Sales to be released at 10:00 ET
- February Consumer Sentiment to be released at 09:55 ET
- Churchill Downs acquires assets of Bluff Media
- Mario Monti: Far from certain there will be a Greek default, CNBC reports
- Energen to acquire proved Wolfberry properties
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?

